Rocket Pharmaceuticals, Inc.RCKTNASDAQ
LOADING
|||
Cash Flow Under Pressure
Below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-215.59M
↓ 101% below average
Average (9y)
$-107.12M
Historical baseline
Range
High:$-17.83M
Low:$-215.59M
CAGR
+31.9%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-215.59M | -2.0% |
| 2023 | $-211.39M | -13.2% |
| 2022 | $-186.76M | -44.9% |
| 2021 | $-128.88M | -24.3% |
| 2020 | $-103.70M | -17.9% |
| 2019 | $-87.93M | -59.2% |
| 2018 | $-55.24M | -111.0% |
| 2017 | $-26.18M | +30.6% |
| 2016 | $-37.75M | -111.8% |
| 2015 | $-17.83M | - |